117 related articles for article (PubMed ID: 14601513)
1. Mutagenesis by retroviral transgene insertion: risk assessment and potential alternatives.
Baum C; Fehse B
Curr Opin Mol Ther; 2003 Oct; 5(5):458-62. PubMed ID: 14601513
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
3. Retroviral bicistronic vectors.
Pfützner W
Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
[TBL] [Abstract][Full Text] [Related]
4. Using RT-prone recombination to promote re-building of complete retroviral vectors from two defective precursors: low efficiency and sequence specificities.
Bru T; Galetto R; Piver E; Collin C; Negroni M; Pagès JC
J Virol Methods; 2007 Jun; 142(1-2):118-26. PubMed ID: 17336399
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy in retrovirally modified haematopoietic cell therapy.
Li Z; Modlich U; Baum C
Best Pract Res Clin Haematol; 2004 Sep; 17(3):493-503. PubMed ID: 15498719
[TBL] [Abstract][Full Text] [Related]
6. Retroviral integration site analysis in hematopoietic stem cells.
Kustikova OS; Baum C; Fehse B
Methods Mol Biol; 2008; 430():255-67. PubMed ID: 18370305
[TBL] [Abstract][Full Text] [Related]
7. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
Werner M; Kraunus J; Baum C; Brocker T
Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
[TBL] [Abstract][Full Text] [Related]
8. Transposable elements for transgenesis and insertional mutagenesis in vertebrates: a contemporary review of experimental strategies.
Ivics Z; Izsvák Z
Methods Mol Biol; 2004; 260():255-76. PubMed ID: 15020812
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of retroviral integration and mutagenesis.
Cavazza A; Moiani A; Mavilio F
Hum Gene Ther; 2013 Feb; 24(2):119-31. PubMed ID: 23330935
[TBL] [Abstract][Full Text] [Related]
10. Somatic transgenesis using retroviral vectors in the chicken embryo.
Ishii Y; Reese DE; Mikawa T
Dev Dyn; 2004 Mar; 229(3):630-42. PubMed ID: 14991718
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
12. Insertional mutagenesis in gene therapy and stem cell biology.
Baum C
Curr Opin Hematol; 2007 Jul; 14(4):337-42. PubMed ID: 17534158
[TBL] [Abstract][Full Text] [Related]
13. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
14. [Transgene complete silencing may associate with rearrangement of retroviral vector].
Wang D; Xiao L; Ma Q; Zhai F; Ren S; Li C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):342-6. PubMed ID: 21604499
[TBL] [Abstract][Full Text] [Related]
15. Strategies in generating transgenic mammals.
Jacenko O
Methods Mol Biol; 1997; 62():399-424. PubMed ID: 9108537
[No Abstract] [Full Text] [Related]
16. Applying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.
Orbán TI; Apáti A; Németh A; Varga N; Krizsik V; Schamberger A; Szebényi K; Erdei Z; Várady G; Karászi E; Homolya L; Német K; Gócza E; Miskey C; Mátés L; Ivics Z; Izsvák Z; Sarkadi B
Stem Cells; 2009 May; 27(5):1077-87. PubMed ID: 19415778
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gene transfer rate with immobilized retroviral vectors.
Peng CA
Ann N Y Acad Sci; 2009 Apr; 1161():26-33. PubMed ID: 19426303
[TBL] [Abstract][Full Text] [Related]
18. Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
[TBL] [Abstract][Full Text] [Related]
19. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
[TBL] [Abstract][Full Text] [Related]
20. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
